Your browser doesn't support javascript.
loading
Expanding the clinical relevance of the 5'-nucleotidase cN-II/NT5C2.
Jordheim, Lars Petter.
Afiliação
  • Jordheim LP; Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Faculté Rockefeller, Centre de Recherche en Cancérologie de Lyon, 8 avenue Rockefeller, 69008, Lyon, France. lars-petter.jordheim@univ-lyon1.fr.
Purinergic Signal ; 14(4): 321-329, 2018 12.
Article em En | MEDLINE | ID: mdl-30362044
ABSTRACT
Purine metabolism is depending on a large amount of enzymes to ensure cellular homeostasis. Among these enzymes, we have been interested in the 5'-nucleotidase cN-II and its role in cancer biology and in response of cancer cells to treatments. This protein has been cited and studied in a large number of papers published during the last decade for its involvement in non-cancerous pathologies such as hereditary spastic paraplegia, schizophrenia, and blood pressure regulation. Here, we review these articles in order to give an overview of the recently discovered clinical relevance of cN-II.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paraplegia / 5'-Nucleotidase / Homeostase Limite: Animals / Humans Idioma: En Revista: Purinergic Signal Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paraplegia / 5'-Nucleotidase / Homeostase Limite: Animals / Humans Idioma: En Revista: Purinergic Signal Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França